These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 8301680

  • 1. Ocular manifestations in bone marrow transplantation.
    Spires R.
    J Ophthalmic Nurs Technol; 1993; 12(5):208-10. PubMed ID: 8301680
    [Abstract] [Full Text] [Related]

  • 2. Dry eye syndrome in long-term follow-up of bone marrow transplanted patients.
    Calissendorff B, el Azazi M, Lönnqvist B.
    Bone Marrow Transplant; 1989 Nov; 4(6):675-8. PubMed ID: 2819286
    [Abstract] [Full Text] [Related]

  • 3. Ocular complications in high-dose chemoradiotherapy and marrow transplantation.
    Jack MK, Hicks JD.
    Ann Ophthalmol; 1981 Jun; 13(6):709-11. PubMed ID: 7020552
    [Abstract] [Full Text] [Related]

  • 4. Ocular manifestations of graft versus host disease following bone marrow transplantation.
    Claes K, Kestelyn P.
    Bull Soc Belge Ophtalmol; 2000 Jun; (277):21-6. PubMed ID: 11126670
    [Abstract] [Full Text] [Related]

  • 5. Ocular findings after bone marrow transplantation in a pediatric population.
    Suh DW, Ruttum MS, Stuckenschneider BJ, Mieler WF, Kivlin JD.
    Ophthalmology; 1999 Aug; 106(8):1564-70. PubMed ID: 10442905
    [Abstract] [Full Text] [Related]

  • 6. Ocular complications of bone marrow transplantation.
    Livesey SJ, Holmes JA, Whittaker JA.
    Eye (Lond); 1989 Aug; 3 ( Pt 3)():271-6. PubMed ID: 2693135
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
    Karwacka E, Ołdakowska-Jedynak U, Brydak-Godowska J, Paczek L, Kecik D.
    Transplant Proc; 2006 Aug; 38(1):292-4. PubMed ID: 16504728
    [Abstract] [Full Text] [Related]

  • 9. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects.
    Tichelli A, Duell T, Weiss M, Socié G, Ljungman P, Cohen A, van Lint M, Gratwohl A, Kolb HJ.
    Bone Marrow Transplant; 1996 Jun; 17(6):1105-11. PubMed ID: 8807122
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
    Ozawa S, Nakaseko C, Nishimura M, Maruta A, Cho R, Ohwada C, Sakamaki H, Sao H, Mori S, Okamoto S, Miyamura K, Kato S, Kawase T, Morishima Y, Kodera Y, Japan Marrow Donor Program.
    Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bone marrow infarction due to acute graft-versus-host disease in an acute lymphoblastic leukemia patient after unrelated bone marrow transplantation.
    Mori A, Hashino S, Imamura M, Kahata K, Kawakami H, Shibata M, Kobayashi S, Tanaka J, Asaka M.
    Bone Marrow Transplant; 1998 Mar; 21(6):615-7. PubMed ID: 9543066
    [Abstract] [Full Text] [Related]

  • 14. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 15. Sjögren-like syndrome after bone marrow transplantation.
    Kosrirukvongs P, Chirapapaisan N, Visuthisakchai S, Issaragrisil S, Gonggetyai V.
    J Med Assoc Thai; 2008 Nov; 91(11):1739-47. PubMed ID: 19127798
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
    Belkacémi Y, Ozsahin M, Rio B, Laporte JP, Leblond V, Pène F, Laugier A.
    Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
    [Abstract] [Full Text] [Related]

  • 18. Progressive corneal vascularization caused by graft-versus-host disease.
    Mohammadpour M.
    Cornea; 2007 Feb; 26(2):225-6. PubMed ID: 17251819
    [Abstract] [Full Text] [Related]

  • 19. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
    Ji SQ, Chen HR, Wang HX, Yan HM, Liu J, Xue M, Zhu L.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179
    [Abstract] [Full Text] [Related]

  • 20. [A 0,05% cyclosporine treatment of the advanced dry eye syndrome].
    Kujawa A, Rózycki R.
    Klin Oczna; 2005 Aug; 107(4-6):280-6. PubMed ID: 16118939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.